Psychedelic-Assisted Therapies for Anxiety and Alcohol Use Disorder (AUD)
August 30, 2024 DOI: 10.64239/pi-vl8207 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Interventions | LSD-assisted therapy Psilocybin-assisted therapy |
|---|---|
| Topics | Addiction Anxiety Psychedelic-assisted therapy |
| Key points | LSD-assisted therapy may reduce anxiety but can cause adverse effects like paranoia, and psilocybin-assisted therapy shows promise for alcohol use disorder but improvements may be partly due to extensive psychotherapy. |
Abstract
LSD-assisted therapy may reduce anxiety, but a recent study saw adverse effects like paranoia requiring antipsychotics and overnight monitoring in one participant. Psilocybin-assisted therapy showed promise for alcohol use disorder compared to placebo, but the study also involved extensive psychotherapy which likely contributed to improvements. Psychological risks exist and must be considered as these treatments become medicalized.